Skip to main content

Table 2 Laboratory examinations within first 24 h of ICU admission

From: Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Characteristic

ACEi/ARB median (IQR)

Available number

Non-ACEi/ARB median (IQR)}

Available number

Haemoglobin (g/L)

12.7 (11.1–13.8)

414

11.4 (9.6–13.3)

165

Neutrophil (109/L)

8.7 (5.7–11.9)

307

7.1 (4.2–11.0)

100

Lymphocyte (109/L)

0.8 (0.5–1.2)

319

0.7 (0.4–1.1)

111

Platelets (109/L)

220 (168–280)

395

190 (134–261)

162

C-reactive protein (mg/L)

133 (50–257)

125

118 (36–245)

59

Procalcitonin (ng/mL)

0.30 (0.17–0.94)

141

0.70 (0.25–1.67)

51

Bilirubin (μmol/L)

0.58 (0.35–0.90)

302

0.60 (0.40–1.00)

123

AST (U/L)

0.81 (0.57–1.25)

254

0.82 (0.57–1.20)

105

ALT (U/L)

0.61 (0.38–1.15)

257

0.52 (0.33–0.87)

109

Blood urea nitrogen (mmol/L)

2.1 (1.2–3.6)

359

2.1 (1.2–4.0)

153

Creatinine (μmol/L)

1.1 (0.8–1.6)

412

1.2 (0.9–2.2)

165

Sodium (mmol/L)

137 (134–140)

331

139 (135–142)

130

Potassium (mmol/L)

4.1 (3.7–4.6)

332

4.2 (3.7–4.7)

130

  1. ACEi angiotensin-converting enzyme inhibitor, ALT alanine aminotransferase, ARB angiotensin II receptor blocker, AST aspartate aminotransferase